BridgeBio PharmaBBIO
那斯達克 · USD
68.58
-3.80
(-5.25%)
盤中 09/16 03:08 (UTC+8)
09/16 03:08 (UTC+8)
BridgeBio PharmaBBIO
68.58
-3.80
(-5.25%)
財務數據
損益表
- 2.11
- 0.02
- 0.03
- 0.06
- 1.17
- 1.11
- 1.21
- 1.54
- 1.95
- 2.44
- 11998.57
- -98.97
- 26.01
- 115.30
- 1882.88
- -5.20
- 9.17
- 27.74
- 26.16
- 25.27
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 243,676 | 194,515 | 154,178 | 120,700 | 110,565 | 116,633 | 5,882 | 2,732 | 2,168 | 211,120 |
營業成本 | 15,046 | 9,939 | 8,107 | 6,563 | 3,653 | 2,639 | 2,084 | 598 | 598 | 598 |
營業毛利 | 228,630 | 184,576 | 146,071 | 114,137 | 106,912 | 113,994 | 3,798 | 2,134 | 1,570 | 210,522 |
營業費用 | 335,709 | 290,532 | 285,633 | 259,336 | 241,190 | - | 229,825 | - | - | - |
研發費用 | 149,448 | 126,636 | 116,417 | 112,874 | 111,231 | 111,431 | 130,350 | 120,444 | 114,695 | 140,972 |
推銷及管理費用 | 186,261 | 163,896 | 158,085 | 137,621 | 129,154 | 106,365 | 94,782 | 68,819 | 59,523 | 65,807 |
非經常性項目費用 | - | - | 11,131 | 8,841 | 805 | 570 | 4,693 | 4,621 | 2,891 | 3,400 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -107,079 | -105,956 | -139,562 | -145,199 | -134,278 | -104,372 | -226,027 | -191,750 | -175,539 | 343 |
其他收入及費用 | 12,246 | 10,499 | 16,150 | 22,700 | 10,446 | -7,539 | 6,307 | 57,120 | 130,857 | -13,032 |
利息費用 | 54,623 | 52,815 | 50,314 | 48,149 | 37,637 | 42,141 | 29,821 | 23,061 | 22,937 | 23,471 |
稅前純益 | -155,891 | -166,555 | -194,755 | -186,482 | -181,658 | -169,608 | -266,236 | -164,254 | -75,544 | -36,160 |
所得稅 | - | - | -120 | -1,545 | - | - | 1,153 | - | - | - |
稅後純益 | -158,651 | -182,326 | -213,892 | -198,577 | -202,092 | -182,978 | -281,745 | -168,603 | -81,381 | -35,216 |
基本每股稅後盈餘(元) | -0.78 | -0.84 | -1.00 | -0.95 | -0.95 | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 |
稀釋每股稅後盈餘(元) | -0.78 | -0.84 | -0.99 | -0.95 | -0.96 | -0.88 | -1.42 | -0.87 | -0.39 | -0.20 |
基本平均股數(千股) | 195785.00 | 194789.00 | 193552.00 | 191854.00 | 190517.00 | 190145.00 | 189437.00 | 188510.00 | 187586.00 | 178705.00 |
稀釋平均股數(千股) | 195785.00 | 194789.00 | 193552.00 | 191854.00 | 190517.00 | 190145.00 | 189437.00 | 188510.00 | 187586.00 | 178705.00 |
還原基本每股稅後盈餘(元) | -0.78 | -0.84 | -1.00 | -0.95 | -0.95 | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 |
還原稀釋每股稅後盈餘(元) | -0.78 | -0.84 | -0.99 | -0.95 | -0.96 | -0.88 | -1.42 | -0.87 | -0.39 | -0.20 |
還原基本平均股數(千股) | 195,785 | 194,789 | 193,552 | 191,854 | 190,517 | 190,145 | 189,437 | 188,510 | 187,586 | 178,705 |
還原稀釋平均股數(千股) | 195,785 | 194,789 | 193,552 | 191,854 | 190,517 | 190,145 | 189,437 | 188,510 | 187,586 | 178,705 |
EBITDA(千元) | -101,049 | -126,506 | -160,811 | -149,116 | -111,653 | -113,912 | -239,040 | -142,288 | -55,202 | -8,134 |